Johnson & Johnson
- SEC CIK
- 0000200406
- Latest filing
- Aug 6, 2026
Holdings in Q4 2021
Holdings as of Dec 31, 2021, filed Feb 14, 2022. Long positions only; changes compare share counts with Q3 2021.
- Positions
- 24
- −1 vs. Q3 2021
- Portfolio value
- $878.4M
- −$261.5M (−22.9%) vs. Q3 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 3,260,869 | $216.2M | 24.6% | 00.0% | Unchanged | History |
| FATEFate Therapeutics Inc | COM | 3,379,064 | $197.7M | 22.5% | 00.0% | Unchanged | History |
| PTGXProtagonist Therapeutics, Inc | COM | 2,449,183 | $83.8M | 9.5% | 00.0% | Unchanged | History |
| LEGNLegend Biotech Corp | SPONSORED ADS | 1,629,173 | $75.9M | 8.6% | 00.0% | Unchanged | History |
| HLTHCue Health Inc. | COM | 5,548,864 | $74.4M | 8.5% | 00.0% | Unchanged | History |
| MGTXMeiraGTx Holdings plc | COM | 2,898,550 | $68.8M | 7.8% | 00.0% | Unchanged | History |
| CVRXCVRx, Inc. | COM | 3,495,575 | $42.8M | 4.9% | 00.0% | Unchanged | History |
| XNCRXencor Inc | COM | 748,062 | $30.0M | 3.4% | +748,062 | New | History |
| PRCTPROCEPT BioRobotics Corp | COM | 1,018,478 | $25.5M | 2.9% | 00.0% | Unchanged | History |
| FUSNFusion Pharmaceuticals Inc. | COM | 3,670,516 | $15.3M | 1.7% | 00.0% | Unchanged | History |
| ACETAdicet Bio, Inc. | COM | 728,944 | $12.7M | 1.5% | 00.0% | Unchanged | History |
| VORVor Biopharma Inc. | COM | 1,074,658 | $12.5M | 1.4% | 00.0% | Unchanged | History |
| PNTPOINT Biopharma Global Inc. | COM | 1,000,000 | $5.60M | 0.6% | 00.0% | Unchanged | History |
| PHASPhaseBio Pharmaceuticals Inc | COM | 1,607,044 | $4.19M | 0.5% | 00.0% | Unchanged | History |
| HLSQTessera Defense & Homeland Security Inc. | COM | 2,133,402 | $3.41M | 0.4% | 00.0% | Unchanged | History |
| SLGCSomaLogic, Inc. | CLASS A COM | 281,052 | $3.27M | 0.4% | 00.0% | Unchanged | History |
| NNOXNano-X Imaging Ltd. | ORD SHS | 192,429 | $2.80M | 0.3% | +192,429 | New | History |
| ALDXAldeyra Therapeutics, Inc. | COM | 394,834 | $1.58M | 0.2% | 00.0% | Unchanged | History |
| CSLTCastlight Health, Inc. | CL B | 811,295 | $1.25M | 0.1% | 00.0% | Unchanged | History |
| TCONTracon Pharmaceuticals, Inc. | COM NEW | 84,003 | $233.0K | <0.1% | 00.0% | Unchanged | History |
| LUNGPulmonx Corp | COM | 5,639 | $181.0K | <0.1% | 00.0% | Unchanged | History |
| SENSSenseonics Holdings, Inc. | COM | 54,621 | $146.0K | <0.1% | 00.0% | Unchanged | History |
| CALCCalciMedica, Inc. | COM SHS | 49,547 | $91.0K | <0.1% | 00.0% | Unchanged | History |
| GYREGyre Therapeutics, Inc. | COM NEW | 66,951 | $61.0K | <0.1% | 00.0% | Unchanged | History |
Sold out since Q3 2021 (3)
Positions held at the end of Q3 2021 that are gone from this filing.